$HCMC
Healthier Choices Management Corp.

2020 Q2 Form 10-Q Financial Statement

#000084485620000028 Filed on August 19, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2 2019 Q1
Revenue $3.309M $3.817M $4.380M
YoY Change -13.31% 16.45% 21.42%
Cost Of Revenue $1.936M $2.155M $2.477M
YoY Change -10.17% 16.68% 26.2%
Gross Profit $1.373M $1.662M $1.903M
YoY Change -17.39% 16.15% 15.71%
Gross Profit Margin 41.5% 43.55% 43.44%
Selling, General & Admin $2.534M $2.990M
YoY Change 25.52% -4.63%
% of Gross Profit 152.47% 157.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $138.7K $150.0K $152.3K
YoY Change -7.49% 66.78% 73.97%
% of Gross Profit 10.1% 9.02% 8.0%
Operating Expenses $2.168M $2.534M $2.990M
YoY Change -14.45% 25.52% -4.63%
Operating Profit -$794.9K -$872.2K -$1.088M
YoY Change -8.87% 48.33% -27.06%
Interest Expense -$23.82K -$32.12K -$24.27K
YoY Change -25.84% -250.3% -313.08%
% of Operating Profit
Other Income/Expense, Net -$23.82K -$32.11K -$24.97K
YoY Change -25.84% -129.87% -111.89%
Pretax Income -$818.7K -$904.3K -$1.113M
YoY Change -9.47% 96.96% -12.37%
Income Tax
% Of Pretax Income
Net Earnings -$818.7K -$904.3K -$1.113M
YoY Change -9.47% 96.96% -12.37%
Net Earnings / Revenue -24.74% -23.69% -25.4%
Basic Earnings Per Share
Diluted Earnings Per Share -$10.08 -$13.57 -$16.70
COMMON SHARES
Basic Shares Outstanding 85.44B 66.63B shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2019 Q2 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.160M $5.088M $6.060M
YoY Change -77.2% -31.42% -20.88%
Cash & Equivalents $1.147M $5.043M $5.995M
Short-Term Investments $12.86K $45.86K $65.14K
Other Short-Term Assets $298.5K $369.7K $443.7K
YoY Change -19.26% 305.22% 302.23%
Inventory $1.780M $2.019M $1.926M
Prepaid Expenses
Receivables $26.99K $54.06K $57.96K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.265M $7.531M $8.487M
YoY Change -56.64% -10.98% -3.71%
LONG-TERM ASSETS
Property, Plant & Equipment $287.8K $5.047M $5.251M
YoY Change -94.3% 860.14% 863.6%
Goodwill $956.0K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $142.7K $144.1K $143.6K
YoY Change -1.01% 23.27% 22.83%
Total Long-Term Assets $9.912M $9.205M $9.535M
YoY Change 7.68% 250.33% 258.15%
TOTAL ASSETS
Total Short-Term Assets $3.265M $7.531M $8.487M
Total Long-Term Assets $9.912M $9.205M $9.535M
Total Assets $13.18M $16.74M $18.02M
YoY Change -21.26% 50.94% 57.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $929.8K $988.8K $1.296M
YoY Change -5.97% 51.48% 180.41%
Accrued Expenses $536.2K $495.1K $525.1K
YoY Change 8.3% 72.59% 12.94%
Deferred Revenue $21.39K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.651M $2.282M $2.151M
YoY Change 16.16% 105074.19% 100400.47%
Total Short-Term Liabilities $4.139M $5.656M $5.935M
YoY Change -26.82% -49.52% -47.1%
LONG-TERM LIABILITIES
Long-Term Debt $1.237M $1.010M $1.081M
YoY Change 22.43% 10694.98% 10808.07%
Other Long-Term Liabilities $3.335M $3.566M $3.681M
YoY Change -6.46%
Total Long-Term Liabilities $4.573M $4.576M $4.762M
YoY Change -0.08% 48790.06% 47955.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.139M $5.656M $5.935M
Total Long-Term Liabilities $4.573M $4.576M $4.762M
Total Liabilities $8.711M $10.23M $10.70M
YoY Change -14.86% -8.76% -4.74%
SHAREHOLDERS EQUITY
Retained Earnings -$30.15M
YoY Change
Common Stock $8.756M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.466M $6.504M $7.325M
YoY Change
Total Liabilities & Shareholders Equity $13.18M $16.74M $18.02M
YoY Change -21.26% 50.94% 57.04%

Cashflow Statement

Concept 2020 Q2 2019 Q2 2019 Q1
OPERATING ACTIVITIES
Net Income -$818.7K -$904.3K -$1.113M
YoY Change -9.47% 96.96% -12.37%
Depreciation, Depletion And Amortization $138.7K $150.0K $152.3K
YoY Change -7.49% 66.78% 73.97%
Cash From Operating Activities -$811.6K -$1.029M -$1.061M
YoY Change -21.14% 461.89% 379.89%
INVESTING ACTIVITIES
Capital Expenditures -$13.86K -$29.58K $0.00
YoY Change -53.14% -46.34% -100.0%
Acquisitions
YoY Change
Other Investing Activities $2.630K $45.68K $41.47K
YoY Change -94.24%
Cash From Investing Activities -$11.23K $16.10K $41.47K
YoY Change -169.75% -129.21% -1695.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 807.3K 60.99K -47.21K
YoY Change 1223.58% -11828.85% 8979.04%
NET CHANGE
Cash From Operating Activities -811.6K -1.029M -1.061M
Cash From Investing Activities -11.23K 16.10K 41.47K
Cash From Financing Activities 807.3K 60.99K -47.21K
Net Change In Cash -15.60K -952.1K -1.067M
YoY Change -98.36% 298.69% 375.77%
FREE CASH FLOW
Cash From Operating Activities -$811.6K -$1.029M -$1.061M
Capital Expenditures -$13.86K -$29.58K $0.00
Free Cash Flow -$797.8K -$999.6K -$1.061M
YoY Change -20.19% 680.67% 385.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
929799
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
825860
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
65401
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26992
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5706544
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7618245
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
196254
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
74279
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
83175
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-7665
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
306023000000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
311092000000
CY2019Q4 us-gaap Assets
Assets
14006669
CY2020Q2 us-gaap Assets
Assets
13177057
CY2020Q2 us-gaap Assets Current
AssetsCurrent
3265395
CY2019Q4 us-gaap Assets Current
AssetsCurrent
3641661
us-gaap Gain Loss On Investments
GainLossOnInvestments
-11143
us-gaap Gain Loss On Investments
GainLossOnInvestments
-44999
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
442630
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1147103
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1525415
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-378312
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2018641
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3525415
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7061253
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5042612
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3147103
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87600000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67700000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000000
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87600000000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67700000000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
8755829
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
6769849
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
26823
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
21386
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-25427
CY2019Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
167381
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
26823
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
21386
us-gaap Depreciation And Amortization
DepreciationAndAmortization
286559
us-gaap Depreciation And Amortization
DepreciationAndAmortization
302277
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
216796
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
426591
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1923447
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1795418
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2754665
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2665250
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
411206
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
172341
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
741803
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
959247
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
172341
CY2020Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-1286
CY2019Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-19286
CY2019Q4 us-gaap Goodwill
Goodwill
956000
CY2020Q2 us-gaap Goodwill
Goodwill
956000
us-gaap Gross Profit
GrossProfit
3565185
CY2020Q2 us-gaap Gross Profit
GrossProfit
1373294
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-14400
CY2019Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
869223
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1010905
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2089988
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-818680
us-gaap Net Income Loss
NetIncomeLoss
-2016843
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-904314
us-gaap Net Income Loss
NetIncomeLoss
-1509974
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-104087
us-gaap Gross Profit
GrossProfit
3081184
CY2019Q2 us-gaap Gross Profit
GrossProfit
1662291
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5437
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-275249
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
119686
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9526
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-15747
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-322140
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-320
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4197
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
153951
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
22911
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-11662
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-38409
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-12082
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-39475
CY2019Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-12827
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-22529
us-gaap Interest Paid Net
InterestPaidNet
69520
us-gaap Interest Paid Net
InterestPaidNet
69220
CY2019Q4 us-gaap Inventory Net
InventoryNet
1757012
CY2020Q2 us-gaap Inventory Net
InventoryNet
1779923
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14006669
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13177057
CY2019Q4 us-gaap Liabilities
Liabilities
8104938
CY2020Q2 us-gaap Liabilities
Liabilities
8711021
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4138524
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3690986
us-gaap Line Of Credit Facility Collateral Fees Amount
LineOfCreditFacilityCollateralFeesAmount
2000000
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2000000
CY2020Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2000000
CY2020Q2 us-gaap Loans Payable Current
LoansPayableCurrent
651187
CY2019Q4 us-gaap Loans Payable Current
LoansPayableCurrent
282344
CY2020Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
1237060
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
57570
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13777
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
736680
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-50618
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-32113
CY2020Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
333396
CY2020Q2 us-gaap Number Of Stores
NumberOfStores
9
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3335437
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3544729
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
555959
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23815
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-57081
CY2019Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
343387
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
536152
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
2534492
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
2168159
us-gaap Operating Expenses
OperatingExpenses
5524947
us-gaap Operating Expenses
OperatingExpenses
4540540
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4396343
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4663019
us-gaap Operating Income Loss
OperatingIncomeLoss
-1459356
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-872201
us-gaap Operating Income Loss
OperatingIncomeLoss
-1959762
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-794865
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
146865
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
142668
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
4584
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
24663
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
89415
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25000
CY2020Q2 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
20200000
CY2019Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
20200000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
20150
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
20150
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
20150116
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
20150116
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
20150
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
20150
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div><div style="background-color: #FFFFFF;"><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;"><font style="background-color: #FFFFFF;">Reclassification</font></div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Certain amounts in the consolidated financial statements and related notes have been reclassified to conform to the current year presentation. Such reclassifications do not impact the Company's previously reported financial position or net income (loss).</div></div><div><br /></div></div></div>
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
736680
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-117763
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
131540
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0
us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
87154
us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
9991
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
287837
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
332290
CY2019Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2000000
CY2020Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2000000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30146453
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28636479
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3308912
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8197119
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3817013
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7345083
us-gaap Share Based Compensation
ShareBasedCompensation
74279
us-gaap Share Based Compensation
ShareBasedCompensation
196254
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
83175
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
-7665
CY2020Q2 us-gaap Short Term Investments
ShortTermInvestments
12857
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
24000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
4466036
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5901731
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
5292381
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
8426769
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
7324754
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
6504066
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;">Use of Estimates in the Preparation of the Financial Statements</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of net revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include allowances, reserves and write-downs of receivables and inventory, valuing equity securities and hybrid instruments, share-based payment arrangements, deferred taxes and related valuation allowances, and the valuation of the assets and liabilities acquired in business combinations. Certain of management&#8217;s estimates could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. The Company re-evaluates all of its accounting estimates at least quarterly based on these conditions and records adjustments when necessary.</div><div><br /></div></div></div>
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66642629630
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
75564076780
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
81189670235
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66635948138
dei Entity Address Address Line1
EntityAddressAddressLine1
3800 NORTH 28TH WAY
dei Amendment Flag
AmendmentFlag
false
dei City Area Code
CityAreaCode
888
dei Entity Address City Or Town
EntityAddressCityOrTown
HOLLYWOOD
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Local Phone Number
LocalPhoneNumber
766-5351
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33020
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Healthier Choices Management Corp.
dei Entity Central Index Key
EntityCentralIndexKey
0000844856
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1070932
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
105110848016
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity File Number
EntityFileNumber
001-36469
dei Entity Shell Company
EntityShellCompany
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
true
hcmc Stock Issued During Period Shares Cashless Exercise Of Warrants
StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants
19859802354
CY2020Q2 hcmc Prepaid Expense And Vendor Deposits Current
PrepaidExpenseAndVendorDepositsCurrent
298520
CY2019Q4 hcmc Prepaid Expense And Vendor Deposits Current
PrepaidExpenseAndVendorDepositsCurrent
269833
hcmc Contract With Customer Liability Fulfillment Of Contract
ContractWithCustomerLiabilityFulfillmentOfContract
270698
hcmc Contract With Customer Liability Fulfillment Of Contract
ContractWithCustomerLiabilityFulfillmentOfContract
224
hcmc Contract With Customer Liability Breakage Recognized
ContractWithCustomerLiabilityBreakageRecognized
-244
hcmc Contract With Customer Liability Breakage Recognized
ContractWithCustomerLiabilityBreakageRecognized
-1222
hcmc Contract With Customer Liability Redeemed
ContractWithCustomerLiabilityRedeemed
47580
hcmc Contract With Customer Liability Redeemed
ContractWithCustomerLiabilityRedeemed
67781
hcmc Contract With Customer Liability Issued
ContractWithCustomerLiabilityIssued
42611
hcmc Contract With Customer Liability Issued
ContractWithCustomerLiabilityIssued
64452
hcmc Contract Liabilities Expected Period To Be Recognized
ContractLiabilitiesExpectedPeriodToBeRecognized
P24M
CY2020Q2 hcmc Stock Issued During Period Value Cashless Exercise Of Warrants
StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
0
hcmc Stock Issued During Period Value Cashless Exercise Of Warrants
StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
0
CY2019Q2 hcmc Stock Issued During Period Value Cashless Exercise Of Warrants
StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
451
hcmc Stock Issued During Period Value Cashless Exercise Of Warrants
StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
901
hcmc Increase Decrease In Prepaid Expense And Vendor Deposits
IncreaseDecreaseInPrepaidExpenseAndVendorDeposits
28687
hcmc Increase Decrease In Prepaid Expense And Vendor Deposits
IncreaseDecreaseInPrepaidExpenseAndVendorDeposits
-34893
hcmc Amortization Of Right Of Use Asset
AmortizationOfRightOfUseAsset
266676
hcmc Amortization Of Right Of Use Asset
AmortizationOfRightOfUseAsset
327287
hcmc Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
229098
hcmc Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
288850
CY2020Q2 hcmc Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
396143

Files In Submission

Name View Source Status
0000844856-20-000028-index-headers.html Edgar Link pending
0000844856-20-000028-index.html Edgar Link pending
0000844856-20-000028.txt Edgar Link pending
0000844856-20-000028-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
hcmc-20200630.xml Edgar Link completed
hcmc-20200630.xsd Edgar Link pending
hcmc-20200630_cal.xml Edgar Link unprocessable
hcmc-20200630_def.xml Edgar Link unprocessable
hcmc-20200630_lab.xml Edgar Link unprocessable
hcmc-20200630_pre.xml Edgar Link unprocessable
image1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending